Introduction
This on-demand webcast is comprised of the proceedings from 2 independent live broadcast transmissions, features a panel of experts both experienced with and new to clinical Pulsed Field Ablation (PFA), a non-thermal modality with mechanistic advantages over traditional RF and Cryo ablation. Presentations focus on the latest data, including long-term clinical outcomes, collateral safety and lesion durability. The closing discussions, featuring 2 distinct panel discussion sessions, evaluate upcoming PFA trial design with the experts addressing attendee questions.
Agenda
Access: Click on the presentation titles below to view individual segments of the activity.
Agenda |
|
|
|
Welcome and Introduction |
|
|
PFA Science and System Design |
|
|
Preclinical Foundation |
|
|
PVI Durability and 1-Year Outcomes in Paroxysmal AF Patients |
|
|
Beyond PVI: Results from Persistent AF Lesion Strategies |
|
|
Thermal Injury of the Esophagus and the Promise of PFA |
|
|
Investigations of Clinical Collateral Safety |
|
|
Next Steps in US: The ADVENT Trial |
|
|
Next Steps in the EU: The BEAT-AF Trial |
|
|
Session I: Panel Discussion with Q&A Session Session II: Panel Discussion with Q&A Session |
Educational grant support provided by:
FARAPULSE, INC.
Joint Providership:
MediaSphere Medical, LLC and Ciné-Med
Faculty
Program Directors |
|||||
Vivek Reddy, MD |
Prof. Pierre Jaïs, MD |
||||
Faculty |
|||||
Ante Anic, MD |
|
||||
Prof Thomas Deneke, MD |
|||||
Jacob Koruth, MD |